Aeglea Bio Therapeutics Inc (AGLE)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: AGLE Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2022-08-25	2022-08-25	B Purchase	Souza Marcio Non-Executive Director	90,000 +inf% 0.56 50,472 USD	90,000 +inf%	0.56	50,472 USD
2022-06-10	2022-06-08	PP Planned purchase	Hanley Jr. Michael Conick Chief Commercial Officer Officer	28,200 +352.5% 0.71 20,022 USD	28,200 +352.5%	0.71	20,022 USD
2022-03-18	2022-03-16	B Purchase	Quinn Anthony G. President & CEO Executive Director	80,079 +17.0% 2.34 187,705 USD	80,079 +17.0%	2.34	187,705 USD
2022-03-15	2022-03-15	B Purchase	Quinn Anthony G. President & CEO Executive Director	42,417 +9.8% 1.86 78,942 USD	42,417 +9.8%	1.86	78,942 USD
2022-03-15	2022-03-14	B Purchase	Quinn Anthony G. President & CEO Executive Director	67,472 +18.6% 1.93 130,221 USD	67,472 +18.6%	1.93	130,221 USD
2022-03-15	2022-03-11	B Purchase	Quinn Anthony G. President & CEO Executive Director	34,777 +10.6% 2.06 71,780 USD	34,777 +10.6%	2.06	71,780 USD
2022-03-15	2022-03-11	B Purchase	Alspaugh Jonathan Chief Financial Officer Officer	75,000 +83.0% 2.08 156,000 USD	75,000 +83.0%	2.08	156,000 USD
2021-12-13	2021-12-13	B Purchase	Shanafelt Armen Non-Executive Director	14,685 +10.9% 3.65 53,600 USD	14,685 +10.9%	3.65	53,600 USD
2021-12-13	2021-12-10	PP Planned purchase	Quinn Anthony G. President & CEO Executive Director	10,526 +3.3% 3.75 39,473 USD	10,526 +3.3%	3.75	39,473 USD
2021-12-13	2021-12-10	B Purchase	Shanafelt Armen Non-Executive Director	13,516 +11.1% 3.65 49,333 USD	13,516 +11.1%	3.65	49,333 USD
2021-12-13	2021-12-09	PP Planned purchase	Quinn Anthony G. President & CEO Executive Director	43,108 +15.7% 3.70 159,500 USD	43,108 +15.7%	3.70	159,500 USD
2021-12-13	2021-12-09	B Purchase	Shanafelt Armen Non-Executive Director	121,799 +inf% 3.67 446,759 USD	121,799 +inf%	3.67	446,759 USD
2021-12-13	2021-12-09	B Purchase	Alspaugh Jonathan Chief Financial Officer Officer	50,000 +123.8% 3.72 186,000 USD	50,000 +123.8%	3.72	186,000 USD
2020-05-04	2020-04-30	PP Planned purchase	Quinn Anthony G. President & CEO Executive Director	165,000 +44.2% 4.75 783,750 USD	165,000 +44.2%	4.75	783,750 USD
2019-06-14	2019-06-14	B Purchase	Quinn Anthony G. President & CEO Executive Director	5,282 +1.5% 6.23 32,913 USD	5,282 +1.5%	6.23	32,913 USD
2019-06-14	2019-06-13	B Purchase	Quinn Anthony G. President & CEO Executive Director	14,406 +4.3% 6.17 88,836 USD	14,406 +4.3%	6.17	88,836 USD
2019-06-14	2019-06-12	B Purchase	Quinn Anthony G. President & CEO Executive Director	12,217 +3.8% 6.11 74,705 USD	12,217 +3.8%	6.11	74,705 USD
2019-05-22	2019-05-22	B Purchase	Quinn Anthony G. President & CEO Executive Director	3,809 +1.2% 6.86 26,128 USD	3,809 +1.2%	6.86	26,128 USD
2019-05-22	2019-05-21	B Purchase	Quinn Anthony G. President & CEO Executive Director	13,794 +4.5% 6.89 94,981 USD	13,794 +4.5%	6.89	94,981 USD
2019-05-22	2019-05-20	B Purchase	Quinn Anthony G. President & CEO Executive Director	8,989 +3.0% 6.56 58,923 USD	8,989 +3.0%	6.56	58,923 USD
2019-05-17	2019-05-17	B Purchase	Quinn Anthony G. President & CEO Executive Director	6,218 +2.2% 6.65 41,335 USD	6,218 +2.2%	6.65	41,335 USD
2019-05-17	2019-05-16	B Purchase	Quinn Anthony G. President & CEO Executive Director	5,520 +1.9% 6.83 37,691 USD	5,520 +1.9%	6.83	37,691 USD
2019-05-17	2019-05-15	B Purchase	Quinn Anthony G. President & CEO Executive Director	6,256 +2.3% 6.76 42,269 USD	6,256 +2.3%	6.76	42,269 USD
2019-05-17	2019-02-15	PP Planned purchase	Quinn Anthony G. President & CEO Executive Director	719 +0.3% 7.10 5,103 USD	719 +0.3%	7.10	5,103 USD
2018-09-28	2018-09-27	S Sale	Schuchart Aaron Chief Business Officer Officer	5,900 -70.2% 9.50 56,050 USD	5,900 -70.2%	9.50	56,050 USD
2018-09-28	2018-09-27	S Sale	Schuchart Aaron Chief Business Officer Officer	100 -1.2% 9.55 955 USD	100 -1.2%	9.55	955 USD
2018-12-10	2018-08-15	PP Planned purchase	Quinn Anthony G. President & CEO Executive Director	994 +1.0% 9.13 9,075 USD	994 +1.0%	9.13	9,075 USD
2018-05-14	2018-05-11	S Sale	Novartis Bioventures Ltd	19,550 -0.9% 10.06 196,673 USD	19,550 -0.9%	10.06	196,673 USD
2018-05-11	2018-05-10	S Sale	Novartis Bioventures Ltd	22,725 -1.0% 10.13 230,204 USD	22,725 -1.0%	10.13	230,204 USD
2018-05-11	2018-05-09	S Sale	Novartis Bioventures Ltd	51,230 -2.3% 10.11 517,935 USD	51,230 -2.3%	10.11	517,935 USD
2018-05-09	2018-05-08	S Sale	Novartis Bioventures Ltd	26,557 -1.2% 10.03 266,367 USD	26,557 -1.2%	10.03	266,367 USD
2018-05-09	2018-05-07	S Sale	Novartis Bioventures Ltd	15,548 -0.7% 10.11 157,190 USD	15,548 -0.7%	10.11	157,190 USD
2018-12-10	2018-02-15	PP Planned purchase	Quinn Anthony G. President & CEO Executive Director	2,000 +2.2% 6.02 12,040 USD	2,000 +2.2%	6.02	12,040 USD
2017-12-08	2017-12-08	B Purchase	Quinn Anthony G. Interim CEO Executive Director	600 +1.7% 5.07 3,039 USD	600 +1.7%	5.07	3,039 USD
2017-12-08	2017-12-07	B Purchase	Quinn Anthony G. Interim CEO Executive Director	2,800 +8.7% 4.99 13,967 USD	2,800 +8.7%	4.99	13,967 USD
2017-12-08	2017-12-06	B Purchase	Quinn Anthony G. Interim CEO Executive Director	4,888 +18.0% 4.92 24,072 USD	4,888 +18.0%	4.92	24,072 USD
2017-12-05	2017-12-05	B Purchase	Quinn Anthony G.	5,065 +23.0% 4.93 24,976 USD	5,065 +23.0%	4.93	24,976 USD
2017-12-05	2017-12-05	B Purchase	York Charles N II Chief Financial Officer and VP	10,241 +41.7% 4.76 48,700 USD	10,241 +41.7%	4.76	48,700 USD
2017-12-05	2017-12-04	B Purchase	Quinn Anthony G.	7,956 +56.4% 4.98 39,624 USD	7,956 +56.4%	4.98	39,624 USD
2017-12-05	2017-12-04	B Purchase	York Charles N II Chief Financial Officer and VP	3,259 +15.3% 4.97 16,197 USD	3,259 +15.3%	4.97	16,197 USD
2017-12-05	2017-12-01	B Purchase	Quinn Anthony G.	4,100 +41.0% 4.53 18,578 USD	4,100 +41.0%	4.53	18,578 USD
2017-12-05	2017-12-01	B Purchase	York Charles N II Chief Financial Officer and VP	6,500 +44.0% 4.59 29,855 USD	6,500 +44.0%	4.59	29,855 USD
2017-12-05	2017-08-15	PP Planned purchase	York Charles N II Chief Financial Officer and VP	1,959 +15.3% 2.52 4,929 USD	1,959 +15.3%	2.52	4,929 USD
2017-02-21	2017-02-21	B Purchase	ORBIMED ADVISORS LLC Large shareholder	7,000 +0.5% 5.36 37,520 USD	7,000 +0.5%	5.36	37,520 USD
2017-02-21	2017-02-17	B Purchase	ORBIMED ADVISORS LLC Large shareholder	71,800 +5.2% 5.19 372,642 USD	71,800 +5.2%	5.19	372,642 USD
2017-02-21	2017-02-16	B Purchase	ORBIMED ADVISORS LLC Large shareholder	30,500 +2.2% 5.04 153,720 USD	30,500 +2.2%	5.04	153,720 USD
2017-12-05	2017-02-15	PP Planned purchase	York Charles N II Chief Financial Officer and VP	2,000 +18.5% 4.28 8,568 USD	2,000 +18.5%	4.28	8,568 USD
2017-12-05	2016-08-15	PP Planned purchase	York Charles N II Chief Financial Officer and VP	2,000 +22.7% 3.99 7,974 USD	2,000 +22.7%	3.99	7,974 USD
2016-04-14	2016-04-12	B Purchase	LILLY ELI & CO Large shareholder	500,000 +24.2% 10.00 5,000,000 USD	500,000 +24.2%	10.00	5,000,000 USD
2016-04-12	2016-04-12	B Purchase	Novartis Bioventures Ltd Large shareholder	300,000 +14.9% 10.00 3,000,000 USD	300,000 +14.9%	10.00	3,000,000 USD
2016-04-12	2016-04-12	B Purchase	Quinn Anthony Non-Executive Director	10,000 +inf% 10.00 100,000 USD	10,000 +inf%	10.00	100,000 USD
2016-04-12	2016-04-12	B Purchase	Cox Russell J. Non-Executive Director	7,000 +inf% 10.00 70,000 USD	7,000 +inf%	10.00	70,000 USD